A. Kato

发表

Differential activation of the μ‐opioid receptor by oxycodone and morphine in pain‐related brain regions in a bone cancer pain model

M. Narita, Tsutomu Suzuki, A. Nakamura, 2013, British journal of pharmacology.

Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models.

Takako Miyoshi, M. Narita, Tsutomu Suzuki, 2009, Journal of pharmacological sciences.

G protein‐gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites

M. Shibasaki, Tsutomu Suzuki, Tomohisa Mori, 2014, British journal of pharmacology.

Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain.

H. Okano, T. Ushijima, Akira Yamashita, 2013, Brain : a journal of neurology.

Effects of milnacipran, a 5‐HT and noradrenaline reuptake inhibitor, on C‐fibre‐evoked field potentials in spinal long‐term potentiation and neuropathic pain

M. Tanabe, H. Ono, H. Ono, 2012, British journal of pharmacology.

Oxycodone-Induced Analgesic Effects in a Bone Cancer Pain Model in Mice

M. Narita, Tsutomu Suzuki, M. Matsumoto, 2008, Oncology.

Distinct Relations Among Plasma Concentrations Required for Different Pharmacological Effects in Oxycodone, Morphine, and Fentanyl

M. Narita, Tsutomu Suzuki, Kayo Hamaguchi, 2011, Journal of pain & palliative care pharmacotherapy.

Role of voltage-dependent calcium channel subtypes in spinal long-term potentiation of C-fiber-evoked field potentials

M. Tanabe, H. Ono, S. Shinohara, 2011, PAIN®.

[Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes].

K. Abe, M. Yasui, S. Shinohara, 2005, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology.

Injury-specific functional alteration of N-type voltage-gated calcium channels in synaptic transmission of primary afferent C-fibers in the rat spinal superficial dorsal horn.

K. Minami, S. Shinohara, A. Kato, 2016, European journal of pharmacology.

Pharmacological characterization of lysophosphatidic acid‐induced pain with clinically relevant neuropathic pain drugs

Y. Yoneda, A. Kato, K. Takasu, 2012, European journal of pain.

Effect of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on C-fiber-evoked field potentials in spinal long-term potentiation and neuropathic pain

M. Tanabe, H. Ono, A. Kato, 2010, Neuroscience Research.

Injury-specific functional alteration of N-type voltage gated calcium channels on C-afferent terminals in substantia gelatinosa of spinal cord

S. Shinohara, A. Kato, K. Takasu, 2009, Neuroscience Research.

Effects of milnacipran, a 5‐HT and noradrenaline reuptake inhibitor, on C‐fibre‐evoked field potentials in spinal long‐term potentiation and neuropathic pain

M. Tanabe, H. Ono, A. Kato, 2012, British journal of pharmacology.

Role of voltage-dependent calcium channel subtypes in spinal long-term potentiation of C-fiber-evoked field potentials

M. Tanabe, H. Ono, S. Shinohara, 2011, PAIN®.